Literature DB >> 8844460

Antineoplastic agents 338. The cancer cell growth inhibitory. Constituents of Terminalia arjuna (Combretaceae).

G R Pettit1, M S Hoard, D L Doubek, J M Schmidt, R K Pettit, L P Tackett, J C Chapuis.   

Abstract

By means of bioassay-guided separation methods, the cancer cell growth inhibitory constituents residing in the bark, stem and leaves of the Mauritius medicinal plant Terminalia arjuna (Combretaceae) were examined. The cancer cell line active components were found to be gallic acid, ethyl gallate, and the flavone luteolin. Only gallic acid was previously known to occur in this plant. Luteolin has a well established record of inhibiting various cancer cell lines and may account for most of the rationale underlying the use of T. arjuna in traditional cancer treatments. Luteolin was also found to exhibit specific activity against the pathogenic bacterium Neisseria gonorrhoeae.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8844460     DOI: 10.1016/S0378-8741(96)01421-3

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  11 in total

1.  Ellagic acid inhibits proliferation and induced apoptosis via the Akt signaling pathway in HCT-15 colon adenocarcinoma cells.

Authors:  Syed Umesalma; Ponnuraj Nagendraprabhu; Ganapasam Sudhandiran
Journal:  Mol Cell Biochem       Date:  2014-10-30       Impact factor: 3.396

2.  Anti-metastatic effects of isolinderalactone via the inhibition of MMP-2 and up regulation of NM23-H1 expression in human lung cancer A549 cells.

Authors:  Cheng-Hung Chuang; Li-Yu Wang; Yuen Man Wong; En-Shyh Lin
Journal:  Oncol Lett       Date:  2018-01-25       Impact factor: 2.967

Review 3.  The medicinal properties and phytochemistry of plants of the genus Terminalia (Combretaceae).

Authors:  I E Cock
Journal:  Inflammopharmacology       Date:  2015-07-31       Impact factor: 4.473

4.  Diallyl sulfide induces apoptosis in Colo 320 DM human colon cancer cells: involvement of caspase-3, NF-kappaB, and ERK-2.

Authors:  Narayanan Sriram; Srinivasan Kalayarasan; Pandurangan Ashokkumar; Ananthasadagopan Sureshkumar; Ganapasam Sudhandiran
Journal:  Mol Cell Biochem       Date:  2008-02-07       Impact factor: 3.396

5.  Characterisation of Polyphenols in Terminalia arjuna Bark Extract.

Authors:  Anumita Saha; V M Pawar; Sujatha Jayaraman
Journal:  Indian J Pharm Sci       Date:  2012-07       Impact factor: 0.975

6.  Cytotoxic potential of Anisochilus carnosus (L.f.) wall and estimation of luteolin content by HPLC.

Authors:  Jaykumar Bhagat; Richard Lobo; Nimmy Kumar; Jessy Elizabeth Mathew; Aravinda Pai
Journal:  BMC Complement Altern Med       Date:  2014-10-28       Impact factor: 3.659

Review 7.  Medicinal properties of Terminalia arjuna (Roxb.) Wight & Arn.: A review.

Authors:  Augustine Amalraj; Sreeraj Gopi
Journal:  J Tradit Complement Med       Date:  2016-03-20

8.  Luteolin, a bioflavonoid inhibits azoxymethane-induced colon carcinogenesis: Involvement of iNOS and COX-2.

Authors:  Ashok Kumar Pandurangan; Suresh Ananda Sadagopan Kumar; Prakash Dharmalingam; Sudhandiran Ganapasam
Journal:  Pharmacogn Mag       Date:  2014-04       Impact factor: 1.085

9.  In-vitro antibacterial, antioxidant potentials and cytotoxic activity of the leaves of Tridax procumbens.

Authors:  Asad Syed; Natarajan Benit; Abdullah A Alyousef; Abdulaziz Alqasim; Mohammed Arshad
Journal:  Saudi J Biol Sci       Date:  2019-12-26       Impact factor: 4.219

Review 10.  Anti-carcinogenic effects of the flavonoid luteolin.

Authors:  Günter Seelinger; Irmgard Merfort; Ute Wölfle; Christoph M Schempp
Journal:  Molecules       Date:  2008-10-22       Impact factor: 4.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.